Myriad Genetics, Inc., a global leader in molecular diagnostics and precision medicine, announced financial results for its fiscal first-quarter 2020, provided an update on recent business highlights and provided revised fiscal year and second-quarter 2020 financial guidance.
November 4, 2019
· 19 min read